Helpline Tollfree +1.800.650.8239 info@clearsynth.com

OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005

We speak your language 

Cilazapril EP impurity D

Impurities
CAT No.
:
CS-O-11089

CAS No.

:

106928-09-0

Molecular Weight

:

417.5

Molecular Formula

:

C22H31N3O5

Purity

:

>98%

HS Code:

:

29049090


 


Useful information

"Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure. It is branded as Dynorm, Inhibace, Vascace and many other names in various countries. None of these are available in the United States as of May 2010.

Of the eight possible stereoisomers, only the all-(S)-form is medically viable.",""



References

Natoff, I.L., et al.: J.cardiovac. Pharmcol., 7, 569 (1985), Szcs, T., et al.: Drugs, 41, Suppl.1, 18 (1991), Pordy, Rc., et al.:cardiology, 86, 41 (1995),



MSDS



Have any questions ?

We normally respond within 8 hours.

Subject :

  Stock Status

  Bulk Pricing

  Custom QTY Quote

  Request MSDS

  Request COA

  Other






Page info:

This page contains information about Cilazapril EP impurity D Cas # 106928-09-0 and its Impurities.

Cilazapril EP impurity D Cilazapril EP impurity D Worldwide Suppliers of Cilazapril EP impurity D Impurities Clearsynth 106928-09-0

Product rating: 9 Cilazapril EP impurity D based on 20 ratings

  1. Impurities

  2. Cilazapril EP impurity D



Keywords

Keywords: Impurities CS-O-11089 Cilazapril EP impurity D Cilazapril 106928-09-0 417.5 C22H31N3O5
Internal standard, Internal standard Cilazapril, HPLC-MS method validation, HPLC-MS method validation Cilazapril, LC-MS-MS method validation, LC-MS-MS method validation Cilazapril, Deuterated internal standard, Deuterated internal standard Cilazapril, Deuterated Cilazapril, Deuterium labeled Cilazapril, Quantitative bioanalytical methods, Quantitative bioanalytical methods Cilazapril, Blood samples Cilazapril, Blood concentrations, Heavy drugs, Analysis, Analysis Cilazapril, Clinical diagnostic, Clinical diagnostic Cilazapril, Dosing Cilazapril, Analytical method development, Internal standard method.



Related result for 'Cilazapril EP impurity D'

- Cilazapril : API Standards

- Cilazapril : Impurities



QUICK ENQUIRY

Specific product requirements



Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(






NORTH AMERICAN SALES AND R&D CENTRE

CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060

ASIA R&D CENTRE

CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T : +91-40-27155481

ASIA OFFICE

CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T : +91-22-45045945